FLowTriever for Acute Massive Pulmonary Embolism (FLAME)

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03027167` - Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty	Phase 4
Not yet recruiting	`NCT05992168` - Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)	N/A
Active, not recruiting	`NCT03761173` - FlowTriever All-Comer Registry for Patient Safety and Hemodynamics

See also

Status

Clinical Trial

Phase

Withdrawn

NCT03027167 - Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty

Phase 4

Not yet recruiting

NCT05992168 - Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)

N/A

Active, not recruiting

NCT03761173 - FlowTriever All-Comer Registry for Patient Safety and Hemodynamics

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04795167
Study type	Observational
Source	Inari Medical
Contact
Status	Completed
Phase
Start date	March 16, 2021
Completion date	December 19, 2022

FLowTriever for Acute Massive Pulmonary Embolism (FLAME) — FLAME

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms